Literature DB >> 31028408

Clinical impact of the gap-angle ratio in patients with ostial lesions of the right coronary artery undergoing percutaneous coronary intervention.

Koichi Ohashi1, Daisuke Abe2, Norihiro Kuroki2, Takao Yuba2, Kou Suzuki2.   

Abstract

The aim of this study was to investigate the incidence of binary restenosis and its predictors in patients with ostial lesions of the right coronary artery (RCAos) who underwent percutaneous coronary intervention (PCI). RCAos are associated with a high incidence of restenosis, and the implantations of drug-eluting stents for RCAos have not been fully elucidated. The study participants included 75 patients (72.3 ± 9.5 years, 72% men) who underwent PCI for RCAos at our institution between November 2001 and May 2017. The angle between the greater curvature of the aortic wall and the right coronary artery take-off in the diastolic and systolic phases in the left anterior oblique position view was investigated. Clinical outcome was defined as binary restenosis at follow-up coronary angiography. We also evaluated target lesion failure (TLF) defined as a composite of cardiac mortality, target vessel myocardial infarction, and target lesion revascularization (TLR). The incidence of binary restenosis was 48.0% (n = 36) of the entire cohort. The incidence of TLF was 49.3% (n = 37) of the entire cohort, which was mainly driven by TLR (36.0%, n = 27). The area under the curve of the gap-angle ratio [(difference between the maximum and minimum angles)/(minimum angle); GAR] for binary restenosis was 0.73, and the cutoff value was 0.306 (sensitivity 67%, specificity 82%). The patients were divided into two groups: a low-GAR (< 0.306; n = 30) and high-GAR group (> 0.306; n = 45). Binary restenosis was more frequent in the high-GAR group than in the low-GAR group (76.7% vs. 28.9%, p = 0.007). The cumulative rate of TLF was significantly higher in the high-GAR group when compared with the low-GAR group (53.3% vs. 40.0%, p = 0.01), which was mainly driven by TLR (56.7% vs. 22.2%, p = 0.01). High-GAR (> 0.306) [OR 2.66 (1.34-5.31), p = 0.005] and stent under expansion [OR 2.37 (1.10-5.11), p = 0.03] were found to be independent predictors of binary restenosis after adjustment for multiple confounders. Multivariable analysis also revealed that high-GAR (> 0.306) [OR 2.06 (1.02-4.14), p = 0.03] and stent under expansion [OR 2.82 (1.28-6.19), p = 0.01] were independent predictors of TLF. We suggest that GAR (> 0.306) predicts binary restenosis and TLF in patients undergoing PCI for RCAos.

Entities:  

Keywords:  Ostial lesion of RCA; Percutaneous coronary intervention; Restenosis

Mesh:

Substances:

Year:  2019        PMID: 31028408     DOI: 10.1007/s00380-019-01417-x

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  26 in total

1.  An Approach to Ostial Lesion Management.

Authors:  Kenneth Chin
Journal:  Curr Interv Cardiol Rep       Date:  2001-05

2.  Stent implantation in aorto-ostial lesions: long-term follow-up and predictors of outcome.

Authors:  André Luz; Christine Hughes; Rui Magalhães; Teodoro Bisceglia; Fleur Descoutures; Khalid Tamamm; Didier Tchetche; Antoine Sauguet; Bruno Farah; Jean Fajadet
Journal:  EuroIntervention       Date:  2012-01       Impact factor: 6.534

3.  Comparison of zotarolimus-eluting and everolimus-eluting coronary stents.

Authors:  Patrick W Serruys; Sigmund Silber; Scot Garg; Robert Jan van Geuns; Gert Richardt; Pawel E Buszman; Henning Kelbaek; Adrianus Johannes van Boven; Sjoerd H Hofma; Axel Linke; Volker Klauss; William Wijns; Carlos Macaya; Philippe Garot; Carlo DiMario; Ganesh Manoharan; Ran Kornowski; Thomas Ischinger; Antonio Bartorelli; Jacintha Ronden; Marco Bressers; Pierre Gobbens; Manuela Negoita; Frank van Leeuwen; Stephan Windecker
Journal:  N Engl J Med       Date:  2010-06-16       Impact factor: 91.245

4.  Comparison of mid-term clinical outcomes after treatment of ostial right coronary artery lesions with early and new generation drug-eluting stents: Insights from an international multicenter registry.

Authors:  Satoru Mitomo; Richard J Jabbour; Yusuke Watanabe; Antonio Mangieri; Marco Ancona; Damiano Regazzoli; Akihito Tanaka; Akihiro Nakajima; Toru Naganuma; Francesco Giannini; Azeem Latib; Sunao Nakamura; Antonio Colombo
Journal:  Int J Cardiol       Date:  2018-01-28       Impact factor: 4.164

5.  Impact of intravascular ultrasound-guided percutaneous coronary intervention on long-term clinical outcomes in a real world population.

Authors:  Seung-Ho Hur; Soo-Jin Kang; Young-Hak Kim; Jung-Min Ahn; Duk-Woo Park; Seung-Whan Lee; Sung-Cheol Yun; Cheol Whan Lee; Seong-Wook Park; Seung-Jung Park
Journal:  Catheter Cardiovasc Interv       Date:  2012-04-09       Impact factor: 2.692

6.  A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial.

Authors:  Clemens von Birgelen; Mounir W Z Basalus; Kenneth Tandjung; K Gert van Houwelingen; Martin G Stoel; J Hans W Louwerenburg; Gerard C M Linssen; Salah A M Saïd; Miep A W J Kleijne; Hanim Sen; Marije M Löwik; Job van der Palen; Patrick M J Verhorst; Frits H A F de Man
Journal:  J Am Coll Cardiol       Date:  2012-02-15       Impact factor: 24.094

7.  Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute.

Authors:  D R Holmes; R E Vlietstra; H C Smith; G W Vetrovec; K M Kent; M J Cowley; D P Faxon; A R Gruentzig; S F Kelsey; K M Detre
Journal:  Am J Cardiol       Date:  1984-06-15       Impact factor: 2.778

8.  Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study.

Authors:  Pedro A Lemos; Angela Hoye; Dick Goedhart; Chourmouzios A Arampatzis; Francesco Saia; Willem J van der Giessen; Eugene McFadden; Georgios Sianos; Pieter C Smits; Sjoerd H Hofma; Pim J de Feyter; Ron T van Domburg; Patrick W Serruys
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

9.  Restenosis after successful coronary angioplasty in patients with single-vessel disease.

Authors:  P P Leimgruber; G S Roubin; J Hollman; G A Cotsonis; B Meier; J S Douglas; S B King; A R Gruentzig
Journal:  Circulation       Date:  1986-04       Impact factor: 29.690

10.  Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents.

Authors:  Melanie Freeman; David J Clark; Nick Andrianopoulos; Stephen J Duffy; Han S Lim; Angela Brennan; Kerrie Charter; James Shaw; Mark Horrigan; Andrew E Ajani; Martin Sebastian; Christopher M Reid; H M Omar Farouque
Journal:  Catheter Cardiovasc Interv       Date:  2009-05-01       Impact factor: 2.692

View more
  1 in total

1.  Left main coronary artery ostial disease: Prognostic role of the gap-angle ratio.

Authors:  Gianluca Rigatelli; Marco Zuin; Pavel Nikolov; Dobrin Vassilev
Journal:  Cardiol J       Date:  2020-11-17       Impact factor: 2.737

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.